Press
Explore Arrive Health in the news.
Our news releases cover a number of awards and recognitions, from our most recent partnerships to our impressive growth.
![Pharmacy Times logo](https://rxrevuprod.wpenginepowered.com/wp-content/uploads/2024/02/Pharmacy-Times-Media-tile.png)
Biosimilars: Are They Delivering the Cost Savings Promised?
Arrive Health answers the question: Does the simple availability of biosimilars drive adoption and anticipated impact on cost?
![Forbes logo](https://rxrevuprod.wpenginepowered.com/wp-content/uploads/2024/01/Forbes-2.png)
Four Ways for Start-Ups to Succeed in Healthcare
Our CEO Kyle Kiser explains lessons from Arrive Health's journey.
![Pharmaceutical Executive](https://rxrevuprod.wpenginepowered.com/wp-content/uploads/2024/01/PharmacyExec-tile.png)
The Real Value of AI in Healthcare? Strengthening the Doctor-Patient Relationship
CEO Kyle Kiser and Executive Advisor Toby Cosgrove, MD, share thoughts about AI and automation's value in healthcare
![ColoradoInno logo](https://rxrevuprod.wpenginepowered.com/wp-content/uploads/2023/11/Colorado-Inno.png)
14 Colorado companies make Deloitte’s 2023 list of fastest-growing tech businesses
Denver-based Arrive Health featured on national list
![](https://rxrevuprod.wpenginepowered.com/wp-content/uploads/2022/11/Deloitte1.png)
Arrive Health Ranks among Fastest-Growing Companies in North America on the 2023 Deloitte Technology Fast 500™
Ranks among America's fastest-growing private companies.
![Blue box](https://rxrevuprod.wpenginepowered.com/wp-content/uploads/2022/06/Press_Card-800x400-Blue.png)
Arrive Health Named to Inc. 5000 List for Third Consecutive Year
Ranks among America's fastest-growing private companies.
![](https://rxrevuprod.wpenginepowered.com/wp-content/uploads/2023/08/Pharmacy-Technology-Report-logo-1.png)
Zero-Cost Medications Available for Nearly Half of Prescriptions, Analysis Finds
Nearly half of transactions for prescription drugs include an option for patients to receive their medication at no out-of-pocket cost, according to Arrive Health analysis.
![Blue box](https://rxrevuprod.wpenginepowered.com/wp-content/uploads/2022/06/Press_Card-800x400-Blue.png)
Arrive Health Featured on NYSE Floor Talk
CEO Kyle Kiser shares how we're helping doctors make lower-cost decisions for patients when prescribing medications
![Blue box](https://rxrevuprod.wpenginepowered.com/wp-content/uploads/2022/06/Press_Card-800x400-Blue.png)
Arrive Health Wins 2023 MedTech Breakthrough Award
Company recognized for Best Electronic Health Record Service
![](https://rxrevuprod.wpenginepowered.com/wp-content/uploads/2022/06/hcitnews.png)
UPMC tackles medication nonadherence, achieves big clinical and financial ROI
Patients who engaged with the technology were 32% less likely to experience a seven-day readmission and 16% less likely to experience a 30-day readmission.
![](https://rxrevuprod.wpenginepowered.com/wp-content/uploads/2023/02/RegionalsToolkit_2023_1200x675_Rocky-Mountain-1.png)
Arrive Health Ranks No. 15 on Inc. Magazine’s List of Fastest-Growing Companies in the Rocky Mountain Region
Arrive Health has ranked number 15 on Inc. Magazine's list of the fastest-growing companies in the Rocky Mountain region.
![Blue box](https://rxrevuprod.wpenginepowered.com/wp-content/uploads/2022/06/Press_Card-800x400-Blue.png)
Arrive Health Analysis Finds $0 Medication Options Available Nearly Half of the Time
Arrive Health has completed an analysis of 78 million prescription transactions and found that 46.78% of the time, patients have an option that would cost $0.